MASCC Score — Febrile Neutropenia Risk
Identify low-risk febrile neutropenia patients suitable for outpatient oral antibiotic therapy. Maximum 26; ≥ 21 = low risk per ESMO oncology guidelines.
MASCC Score
0/26
High risk
Management
Inpatient IV broad-spectrum antibiotics — piperacillin-tazobactam OR cefepime OR meropenem within 60 min of fever onset. Blood cultures × 2, urine culture, CXR. Add vancomycin if catheter-related sepsis, MRSA risk, severe mucositis. G-CSF per COG criteria.
FN sepsis door-to-antibiotic in 60 min
DoctorScribe's oncology module starts a countdown the moment a febrile chemo patient checks in, surfaces MASCC, and pre-orders the first-line antibiotic — the 60-min target you keep missing.
FN protocols, automated
DoctorScribe auto-flags every chemo patient with fever for MASCC scoring, pre-fills the empirical antibiotic order, and books the 24-h reassessment — sepsis-window adherence built in.